New sedative may speed up endoscopy recovery
NCT ID NCT05836545
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested remimazolam against midazolam for sedation during diagnostic upper gastrointestinal endoscopy. 132 healthy adults participated, and researchers measured total procedure time and sedation success. The goal is to see if remimazolam provides faster and more effective sedation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remimazolam
- What this could lead to
- If remimazolam works better, it could offer faster and more reliable sedation for routine endoscopy procedures.
- What could go wrong
- This is a small, completed trial in healthy people, so results may not apply to all patients. Both drugs are already used, so no major breakthrough is expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Samsung Medical Center
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Which medical adhesive stays put longest without itching? a head-to-head test in healthy women.
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- New eye drop aims to tame ocular pain in early trial
- Could a formula closer to breast milk boost baby development?
- Could a daily probiotic help you feel fuller and eat less?